Remix Therapeutics
Cassandra Schaening-Burgos has been working in the field of Bioinformatics and Data Science since 2022, when they started as a Scientist at Remix Therapeutics. Prior to that, they were a Graduate Student at the Massachusetts Institute of Technology (MIT) from 2014 to 2022. Before that, they were a Summer Research Intern at the University of Pittsburgh from 2011 to 2014.
Cassandra Schaening-Burgos obtained a Bachelor of Science (BSc) in Computer Science from the University of Puerto Rico, Rio Piedras in 2014. Cassandra then went on to pursue a Doctor of Philosophy - PhD in Computational and Systems Biology at the Massachusetts Institute of Technology, which they are expected to complete in 2022.
Remix Therapeutics
Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.